Savaria Co. (TSE:SIS – Free Report) – Equities research analysts at Scotiabank reduced their FY2027 EPS estimates for shares of Savaria in a research report issued on Thursday, May 14th. Scotiabank analyst J. Goldman now anticipates that the company will post earnings of $1.48 per share for the year, down from their prior estimate of $1.51. Scotiabank has a “Outperform” rating and a $30.00 price objective on the stock. The consensus estimate for Savaria’s current full-year earnings is $1.20 per share.
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported C$0.31 EPS for the quarter. Savaria had a net margin of 8.50% and a return on equity of 12.41%. The business had revenue of C$235.55 million during the quarter.
View Our Latest Research Report on Savaria
Savaria Price Performance
TSE:SIS opened at C$27.60 on Friday. The business’s 50-day moving average is C$27.54 and its 200 day moving average is C$24.78. Savaria has a 12 month low of C$18.71 and a 12 month high of C$30.62. The company has a market capitalization of C$1.98 billion, a P/E ratio of 25.09, a P/E/G ratio of 42.72 and a beta of 0.97. The company has a current ratio of 1.71, a quick ratio of 0.91 and a debt-to-equity ratio of 31.42.
Insider Activity at Savaria
In related news, insider Jean-Philippe De Montigny bought 2,420 shares of the business’s stock in a transaction dated Friday, March 20th. The shares were purchased at an average price of C$25.50 per share, with a total value of C$61,710.00. Following the transaction, the insider owned 92,260 shares in the company, valued at C$2,352,630. This trade represents a 2.69% increase in their position. Company insiders own 17.45% of the company’s stock.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
- Five stocks we like better than Savaria
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
